PD-L1 antibody (AA 39-191)
Quick Overview for PD-L1 antibody (AA 39-191) (ABIN6939566)
Target
See all PD-L1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 39-191
-
Purification
- Purified by Protein A/G
-
Immunogen
- Recombinant fragment of human CD274 protein (around aa39-191) (exact sequence is proprietary)
-
Isotype
- IgG1 kappa
-
-
-
-
Application Notes
-
Positive Control: Heart, Placenta, Spleen or Tonsil.
Known Application: ELISA (For coating, order antibody without BSA), ,Optimal dilution for a specific application should be determined.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 200 μg/mL
-
Buffer
- 10 mM PBS with0.05 % BSA & 0.05 % azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-80 °C
-
Storage Comment
- Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
-
Expiry Date
- 24 months
-
-
- PD-L1 (CD274 (PD-L1))
-
Alternative Name
- CD274
-
Background
- PD-L1 is a checkpoint regulator in immune cells, it is expressed on immune or non-hematopoietic cells. Expression of the protein is seen during pregnancy where it has a role in suppressing the immune system. PD-L1 induces an inhibitory signal in activated T-cells and promotes T-cell apoptosis. It is overexpressed in a number of different cancers where it is believed to play a significant role in the cancer s ability to evade the immune system.
-
Molecular Weight
- 37-50kDa
-
Gene ID
- 29126
-
UniProt
- Q9NZQ7
-
Pathways
- Cancer Immune Checkpoints
Target
-